RARA CRAFT DATABASE for FDA Medical Devices
510(k)K243448

FDA DEVICE FACTS

Equinoxe® Shoulder System

Exactech, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 1, 2025PRODUCT CODEPHX

Indications for use

The Equinoxe Shoulder System is indicated for use in skeletally mature individuals with degenerative diseases or fractures of the glenohumeral joint where total or hemi-arthroplasty is determined by the surgeon to be the preferred method of treatment. x The cemented primary humeral stem, long/revision stem, fracture stems, and all Equinoxe glenoids are intended for cemented fixation. x The press-fit humeral stems are intended for press-fit applications but may be used with bone cement at the discretion the surgeon. x The reverse humeral components are intended to be used in cemented applications or in revision cases when the humeral component is well-fixed/stable, as deemed by the orthopaedic surgeon. x Humeral Heads are intended for use in cemented and press-fit applications. Clinical indications for the PRIMARY (P), LONG/REVISION (L), and FRACTURE (F) humeral components are as follows: P L F Indications ¥¥ Rheumatoid arthritis, osteoarthritis, osteonecrosis or post-traumatic degenerative problems ¥¥ Congenital abnormalities in the skeletally mature ¥ Primary and secondary necrosis of the humeral head. ¥¥ Humeral head fracture with displacement of the tuberosities ¥¥ Pathologies where arthrodesis or resectional arthroplasty of the humeral head are not acceptable ¥¥ Revisions of humeral prostheses when other treatments or devices have failed (where adequate fixation can be achieved) ¥ Displaced three-part and four-part upper humeral fractures ¥ Spiral and other fractures of the mid-humerus (in combination with glenohumeral degenerative diseases) ¥ Revision of failed previous reconstructions when distal anchorage is required ¥¥ To restore mobility from previous procedures (e.g. previous fusion) The Equinoxe Reverse Shoulder System is indicated for use in skeletally mature individuals with degenerative diseases of the glenohumeral joint and a grossly deficient, irreparable rotator cuff. The Equinoxe Reverse Shoulder is also indicated for a failed glenohumeral joint replacement with loss of rotator cuff function resulting in superior migration of the humeral head. The Equinoxe Platform Fracture Stem is indicated for use in skeletally mature individuals with acute fracture of the proximal humerus and displacement of the tuberosities, displaced 3- and 4-part fractures of the proximal humerus (hemi-arthroplasty), or acute fracture of the proximal humerus with failure of the glenohumeral joint (primary total shoulder arthroplasty). The Equinoxe Platform Fracture Stem is also indicated for acute fracture of the proximal humerus in combination with degenerative diseases of the glenohumeral joint and a grossly deficient, irreparable rotator cuff resulting in superior migration of the humeral head (reverse total shoulder arthroplasty). The Equinoxe Platform Fracture Stem is indicated for cemented use only.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026